Marc Duey
Director/Board Member presso APREA THERAPEUTICS, INC.
Profilo
Marc Duey founded ProMetrics, Inc. in 1994, where he worked as Chief Executive Officer from 1994 to 2020.
Mr. Duey also currently works at Felicitex Therapeutics, Inc., as Chairman from 2014, Cassian Solutions, Inc., as Director, Aprea Therapeutics, Inc., as Independent Director from 2022, Atrin Pharmaceuticals, Inc., as Director, American Society of Clinical Oncology, Inc., as Member, Duce Management LLC, as Managing Partner from 2012, International House Philadelphia, as Trustee, The American Association of Cancer Research, as Member, The American Association of Pharmaceutical Science, as Member, and The Licensing Executive Society, as Member.
Mr. Duey also formerly worked at Atrin Pharmaceuticals LLC, as Director.
Mr. Duey received his undergraduate degree and graduate degree from the University of Ottawa and Masters Business Admin degree from Richard Ivey School of Business.
Posizioni attive di Marc Duey
Società | Posizione | Inizio |
---|---|---|
APREA THERAPEUTICS, INC. | Director/Board Member | 01/05/2022 |
Cassian Solutions, Inc.
Cassian Solutions, Inc. Information Technology ServicesTechnology Services Cassian Solutions, Inc. engages in other technology industry group. The company is headquartered in Phoenixville, PA. | Director/Board Member | - |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the private company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Director/Board Member | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
Duce Management LLC | Corporate Officer/Principal | 01/01/2012 |
International House Philadelphia | Director/Board Member | - |
The American Association of Cancer Research | Corporate Officer/Principal | - |
The American Association of Pharmaceutical Science | Corporate Officer/Principal | - |
The Licensing Executive Society | Corporate Officer/Principal | - |
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Marc Duey
Società | Posizione | Fine |
---|---|---|
░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Marc Duey
University of Ottawa | Graduate Degree |
Richard Ivey School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
APREA THERAPEUTICS, INC. | Health Technology |
Aziende private | 11 |
---|---|
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Atrin Pharmaceuticals LLC engages in discovery and development of proprietary medications. It offers ATRN-502, a p53 activator; and ATRN-507, a dual ligand showing specificity and selectivity against cancer cells. The firm also provides Atrize, a platform that offers phenotypic FACS-based screening that is applicable across R&D, clinical applications, and a tool for personalized medicine. The company was founded by Oren Gilad and Kevin D. Smith in 2011 and is headquartered in Doylestown, PA. | Health Technology |
Felicitex Therapeutics, Inc.
Felicitex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA. | Commercial Services |
ProMetrics, Inc.
ProMetrics, Inc. Packaged SoftwareTechnology Services ProMetrics, Inc. develops an artificial intelligence healthcare data analytics platform. The private company is based in King of Prussia, PA. The company was founded by Marc Duey. | Technology Services |
Cassian Solutions, Inc.
Cassian Solutions, Inc. Information Technology ServicesTechnology Services Cassian Solutions, Inc. engages in other technology industry group. The company is headquartered in Phoenixville, PA. | Technology Services |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the private company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Health Technology |
Duce Management LLC | |
International House Philadelphia | |
The American Association of Cancer Research | |
The American Association of Pharmaceutical Science | |
The Licensing Executive Society |
- Borsa valori
- Insiders
- Marc Duey